<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Name Unknown</title>
    <link>/authors/admin/</link>
    <description>Recent content on Name Unknown</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sun, 01 Apr 2018 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="/authors/admin/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?</title>
      <link>/publication/gbm_meta-analysis1/</link>
      <pubDate>Sun, 01 Apr 2018 00:00:00 +0000</pubDate>
      
      <guid>/publication/gbm_meta-analysis1/</guid>
      <description>We examined the landscape of trials in glioblastoma registered on ClinicalTrials.gov between 2005-2016. Our findings show low patient enrollment, long trial duration, disproportionate allocation of patient to unsuccessful phase III trials, and lack of randomization in phase II.</description>
    </item>
    
    <item>
      <title>Divining responder populations from survival data</title>
      <link>/publication/diving-responder-pops/</link>
      <pubDate>Tue, 01 Sep 2015 00:00:00 +0000</pubDate>
      
      <guid>/publication/diving-responder-pops/</guid>
      <description>We simulated Kaplan-Meier survival curves with varying prognostic and predictive biomarker subgroups to understand whether KM curve shape might be an indicator of underlying patient heterogeneity.</description>
    </item>
    
    <item>
      <title></title>
      <link>/authors/admin/</link>
      <pubDate>Sun, 01 Apr 2018 00:00:00 +0000</pubDate>
      
      <guid>/authors/admin/</guid>
      <description>Alyssa Vanderbeek is a Master&amp;rsquo;s student in Biostatistics at the Columbia University Mailman School of Public Health in New York City. Research interests include improving efficiencies in oncology drug development, development software and algorithms to advance clinical research, and exploring and visualizing data.</description>
    </item>
    
  </channel>
</rss>